rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ILMN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Illumina Inc. stock outperforms competitors on strong trading day
      5h agoMarketWatchILMN
      Illumina Stock Outlook: Is Wall Street Bullish or Bearish?
      16h agoBarchartILMN
      Here's How Much $1000 Invested In Illumina 15 Years Ago Would Be Worth Today
      Nov 17BenzingaILMN
      Illumina Sees Strong Clinical Demand, but Research Recovery Remains in Question
      Nov 17Yahoo FinanceILMN
      Illumina at Jefferies Global Healthcare Conference: growth, margins advance
      Nov 17Investing.comILMNJEF
      Illumina Inc. stock underperforms Monday when compared to competitors
      Nov 16MarketWatchILMN
      Illumina Inc. stock underperforms Friday when compared to competitors
      Nov 13MarketWatchILMN
      Keith Meister Sells $61M Of Illumina Stock As Shares Slip Below Sale Price
      Nov 13BenzingaILMN
      Illumina (ILMN) Stock Sees Modest Fair Value Lift As Analysts Debate Growth Outlook
      Nov 13Yahoo FinanceILMN
      Illumina director Keith Meister sells $61.1M in shares
      Nov 13Investing.comILMN
      Is Illumina Stock Worth The Wait?
      Nov 11Yahoo FinanceILMN
      Missed Illumina's 76% Run? Here Is What Holders Saw

      If Illumina sat on your watchlist instead of in your portfolio, the past year might feel like a missed shot. Investors who held Illumina over the past year are up 76.2%, including dividends. That outcome arrived alongside headlines about NovaSeq X uptake, clinical sequencing demand, and moves into multiomics. The real puzzle is what, back on 10 November 2025, could have signalled that large-scale clinical consumables adoption might matter more than China and funding worries. Narratives are...

      Nov 11Yahoo FinanceILMN
      How Investors May Respond To Illumina (ILMN) Earnings Beat
      Nov 11Yahoo FinanceILMN
      Illumina (ILMN) Unveils Duplex Sequencing Workflow For MRD Research
      Nov 11Yahoo FinanceILMN
      Illumina Bets on Clinical Demand for Growth as Research Funding Uncertainty Persists
      Nov 11Yahoo FinanceILMN
      Illumina Inc. stock underperforms Tuesday when compared to competitors
      Nov 10MarketWatchILMN
      Illumina Inc. stock outperforms competitors on strong trading day
      Nov 9MarketWatchILMN
      Illumina (ILMN) Selected For Singapore Genome Sequencing Program Covering 450,000 People

      Illumina (NasdaqGS:ILMN) has been chosen to perform whole genome sequencing for Singapore's SG-INSIGHT study under National Precision Medicine Phase III. The SG-INSIGHT project targets around 450,000 people, covering roughly one in ten residents of Singapore. The program expands Illumina's earlier work in Singapore from healthy volunteers into broader clinical applications within the public health system. The SG-INSIGHT sequencing mandate for around 450,000 residents is only one part of...

      Nov 3Yahoo FinanceILMN
      Illumina, Inc. (ILMN) Rallied, but Mott Capital Decided to Take Some Profits: Here’s Why
      Nov 3Yahoo FinanceILMN
      The top 5 analyst questions from Illumina’s Q3 earnings call
      Nov 2Yahoo FinanceILMN
      Don't Overlook Illumina (ILMN) International Revenue Trends While Assessing the Stock
      Nov 2Yahoo FinanceILMN
      What Sent Illumina Stock Lower?
      Nov 2Yahoo FinanceILMN
      Illumina (ILMN) Stock Falls After Q3 Results Lift Guidance
      Nov 1Yahoo FinanceILMN
      Why Illumina (ILMN) shares are getting obliterated today
      Oct 31Yahoo FinanceILMN
      Illumina (ILMN) Stock Stays Reasonable After Raised 2026 Guidance
      Oct 31Yahoo FinanceILMN
      Illumina (ILMN) Lifts Outlook Following Q3 Results But Valuation Still Looks Stretched
      Oct 30Yahoo FinanceILMN
      Illumina Inc. stock underperforms Friday when compared to competitors
      Oct 30MarketWatchILMN
      Illumina Inc (ILMN) Q3 2026 Earnings Call Highlights: Raised Guidance, Strong NovaSeq X ...
      Oct 30Yahoo FinanceILMN
      Illumina Sinks 13% on Light Q3 Revenue Despite EPS Beat and Raised Guidance
      Oct 30Yahoo FinanceILMN
      Illumina Crashes As Tariffs, AI Woes Eat Into 157% Run-Up

      Illumina stock crashed Friday, despite beating third-quarter expectations, on tariff confusion and a shaky backdrop for AI.

      Oct 30Investor's Business DailyILMN
      ILMN Q3 Earnings Call Highlights Higher Guidance and Clinical Growth

      Illumina raises its 2026 guidance as strong clinical sequencing demand and NovaSeq X adoption fuel growth despite research weakness and pricing pressures.

      Oct 30Yahoo FinanceILMN
      Illumina, Inc. Q3 2026 Earnings Call Summary
      Oct 30Yahoo FinanceILMN
      Evercore ISI raises Illumina stock price target on Q3 beat
      Oct 30Investing.comILMN
      Why is Illumina stock tumbling today?
      Oct 30Investing.comILMN
      Illumina (ILMN) Reports Q3 Earnings: What Key Metrics Have to Say
      Oct 29Yahoo FinanceILMN
      Illumina Q3 Earnings Call Highlights
      Oct 29Yahoo FinanceILMN
      Illumina Q3 2026 slides: strong beat masks growth concerns
      Oct 29Investing.comILMN
      Earnings call transcript: Illumina beats Q3 2026 estimates but shares fall after hours
      Oct 29Investing.comILMN
      Illumina shares tumble 12% despite earnings beat on China woes
      Oct 29Investing.comILMN
      Illumina Q3 2026 Earnings Call Transcript
      Oct 29BenzingaILMN
      Illumina falls despite boosting full-year profit, revenue guidance

      Illumina stock is declining despite raised 2026 guidance amid slowing growth outlook. Read more here.

      Oct 29Seeking AlphaILMN
      Illumina (ILMN) Q3 Earnings Beat Estimates
      Oct 29Yahoo FinanceILMN
      Illumina (NASDAQ:ILMN) reports sales below analyst estimates in Q3 2026 earnings, stock drops 16%
      Oct 29Yahoo FinanceILMN
      Illumina: Q3 Earnings Snapshot
      Oct 29Yahoo FinanceILMN
      Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026
      Oct 29Yahoo FinanceILMN
      Illumina earnings on deck: Can clinical momentum justify the rally?
      Oct 29Investing.comILMN
      Robert W. Baird Remains a Hold on Illumina (ILMN)

      Detailed price information for Illumina Inc (ILMN-Q) from The Globe and Mail including charting and trades.

      Oct 29The Globe and MailILMN
      Illumina (ILMN) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

      Evaluate the expected performance of Illumina (ILMN) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

      Oct 28Yahoo FinanceILMN
      What to expect from Illumina’s (ILMN) Q3 earnings
      Oct 28Yahoo FinanceILMN
      Illumina To Webcast Upcoming Investor Conference
      Oct 27Yahoo FinanceILMN

      This is the newest page. Registered accounts read further back.